| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
September 24, 2004 |
|
|
| |
|
|
| |
|
|
|
Strategic Research Institute, Crowne Plaza Philadelphia Hotel
November 8-9, 2004
Continuing advances in the understanding of the molecular pharmacology of phosphodiesterases has led to the development of selective inhibitors as therapeutic agents for disease states ranging from cancer and CNS diseases to erectile dysfunction and inflammatory diseases. The vast combination of cellular controlling mechanisms makes PDEs a very attractive drug target. This year’s meeting will once again bring to light new and promising agents, underline the development of agents with the greatest clinical potential, and discuss new challenges.
|
|
|
|
|
|
|
|
Organized by:
|
|
Strategic Research Institute |
|
|
Invited Speakers:
|
|
Join leaders in the industry for some lively discussion in a setting aimed at facilitating the networking of both industry and academia to move the field forward.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
na
|
|
|
|
|
|
|
|
Registration:
|
|
$1395.00 Discounts are available for full-time government employees and academics
|
|
|
E-mail:
|
|
info@srinstitute.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|